These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21962322)

  • 41. [Hyperuricemia and gout: therapeutic indications].
    Pawlotsky Y
    Rev Prat; 1994 Jan; 44(2):206-9. PubMed ID: 8178077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diagnosis and therapy of gout and hyperuricemia].
    Guzmán L
    Rev Med Chil; 1981 Dec; 109(12):1191-7. PubMed ID: 7346920
    [No Abstract]   [Full Text] [Related]  

  • 43. The diagnosis and management of gouty arthritis.
    Edwards NL
    Compr Ther; 1983 Sep; 9(9):14-9. PubMed ID: 6627900
    [No Abstract]   [Full Text] [Related]  

  • 44. The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand.
    Stamp LK; Haslett J; Frampton C; White D; Gardner D; Stebbings S; Taylor G; Grainger R; Kumar R; Kumar S; Kain T; Porter D; Corkill M; Cathro A; Metcalfe S; Wyeth J; Dalbeth N
    Intern Med J; 2016 Sep; 46(9):1075-80. PubMed ID: 27391386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [What is your diagnosis? Acute gout attack].
    Hofmann M; Richter J; Stanga Z; Wermelinger F; Cottagnoud P; Kobel D; Stucki A
    Praxis (Bern 1994); 2006 Nov; 95(48):1871-2. PubMed ID: 17176925
    [No Abstract]   [Full Text] [Related]  

  • 46. Progress in the pharmacotherapy of gout.
    Sundy JS
    Curr Opin Rheumatol; 2010 Mar; 22(2):188-93. PubMed ID: 20110792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimal management of chronic gout: attempting to render the (t)issues crystal-clear.
    Wong ML
    N Z Med J; 2005 Jun; 118(1217):U1533. PubMed ID: 15980907
    [No Abstract]   [Full Text] [Related]  

  • 48. Gout therapeutics: new drugs for an old disease.
    Burns CM; Wortmann RL
    Lancet; 2011 Jan; 377(9760):165-77. PubMed ID: 20719377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A caveat in the management of acute gout.
    Varughese GI; Varghese AI; Tahrani AA
    Am J Med; 2007 Nov; 120(11):e31; author reply e33. PubMed ID: 17976406
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical images: Divergent patterns of joint remodeling following effective urate-lowering therapy in tophaceous gout.
    Dalbeth N; Doyle A; McQueen FM
    Arthritis Rheum; 2011 Jan; 63(1):266. PubMed ID: 20722028
    [No Abstract]   [Full Text] [Related]  

  • 51. Case 3: acute gout-risk factors and inappropriate therapy.
    Weaver AL
    Am J Med; 2006 Nov; 119(11 Suppl 1):S9-12. PubMed ID: 17059914
    [No Abstract]   [Full Text] [Related]  

  • 52. Gout: joint pain and more.
    Harv Mens Health Watch; 2007 Dec; 12(5):1-3. PubMed ID: 18225332
    [No Abstract]   [Full Text] [Related]  

  • 53. Survey on management of gout among Dutch rheumatologists.
    Reinders MK; Jansen TL
    Ann Rheum Dis; 2008 Jul; 67(7):1049. PubMed ID: 18556447
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout.
    Stocker SL; Graham GG; McLachlan AJ; Williams KM; Day RO
    J Rheumatol; 2011 May; 38(5):904-10. PubMed ID: 21285173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gout. Aspects of management.
    Hepburn AL; Rider TG; Jordan KM
    BMJ; 2011 Jan; 342():d115. PubMed ID: 21224313
    [No Abstract]   [Full Text] [Related]  

  • 56. Colchicine in acute gout: optimal dose of colchicine is still elusive.
    Cox AR
    BMJ; 2004 Jan; 328(7434):288; author reply 289. PubMed ID: 14751912
    [No Abstract]   [Full Text] [Related]  

  • 57. [Benziodarone in the basic treatment of gout].
    Ryckewaert A; Puel M; Kuntz D
    Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):33-9. PubMed ID: 5079688
    [No Abstract]   [Full Text] [Related]  

  • 58. [Badly managed gout for decades. Only then do the hands look this way].
    Füessl HS
    MMW Fortschr Med; 2006 May; 148(18):23. PubMed ID: 16736681
    [No Abstract]   [Full Text] [Related]  

  • 59. Long-term management of gout: nonpharmacologic and pharmacologic therapies.
    Chaichian Y; Chohan S; Becker MA
    Rheum Dis Clin North Am; 2014 May; 40(2):357-74. PubMed ID: 24703352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patient related factors are also important in treating gout.
    Chandratre P; Roddy E; Mallen C
    BMJ; 2012 Jan; 344():e191. PubMed ID: 22235018
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.